Patent intelligence · US
US 10532032
Rolled collagen carrier
Rolled collagen carrier
Patent details — US 10532032
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 14, 2020
- Expiration
- Jan 9, 2040
- Applicant
- TAKEDA AS
- Claims
- 14
- CPC classes
- A61K, A61K31/407, A61K31/435, A61K31/55
Quick answer
US 10532032 (Rolled collagen carrier) is held by TAKEDA AS. Status: granted. Granted Jan 14, 2020. Expires Jan 9, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- TAKEDA AS
- Grant date
- Expiration
- Claims
- 14
- CPC classes
- A61K, A61K31/407, A61K31/435, A61K31/55, A61K38/363, A61K38/4833
More from TAKEDA AS
Related pharmaceutical patents in our USPTO index.
-
US 12428403
N-(heterocyclyl and heterocyclylalkyl)-3-benzylpyridin-2-amine derivatives as SSTR4 agonists
granted -
US 12421188
Heterocyclic compound and use thereof
granted -
US 12419890
Administration of sumo-activating enzyme inhibitor and checkpoint inhibitors
granted -
US 12415866
Monoclonal antibody inhibitor of Factor XIIa
granted -
US 12415782
Heterocyclic compound and use thereof
granted -
US 12409210
CNS delivery of therapeutic agents
granted -
US 12404237
Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives
granted -
US 12403154
Administration of sting agonist and checkpoint inhibitors
granted
Frequently asked questions
What is US patent 10532032?
US 10532032 (Rolled collagen carrier) is held by TAKEDA AS. Status: granted. Granted Jan 14, 2020. Expires Jan 9, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10532032?
TAKEDA AS is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 1,436 pharmaceutical patents for this assignee.
When does US 10532032 expire?
Our index shows an expiration date of Jan 9, 2040 (14 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.